
Better Therapeutics, Inc. Common Stock
BTTX
BTTX: Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.
moreShow BTTX Financials
Recent trades of BTTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BTTX's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: System, methods, and apparatuses for managing data for artificial intelligence software and mobile applications in digital health therapeutics Jun. 07, 2022
Federal grants, loans, and purchases
Followers on BTTX's company Twitter account
Number of mentions of BTTX in WallStreetBets Daily Discussion
Recent insights relating to BTTX
Recent picks made for BTTX stock on CNBC
ETFs with the largest estimated holdings in BTTX
Flights by private jets registered to BTTX